Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation

BackgroundCystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to...

Full description

Bibliographic Details
Main Authors: Rudolf, Isa, Pieper, Katharina, Nolte, Helga, Junge, Sibylle, Dopfer, Christian, Sauer-Heilborn, Annette, Ringshausen, Felix C, Tümmler, Burkhard, von Jan, Ute, Albrecht, Urs-Vito, Fuge, Jan, Hansen, Gesine, Dittrich, Anna-Maria
Format: Article
Language:English
Published: JMIR Publications 2019-11-01
Series:JMIR mHealth and uHealth
Online Access:https://mhealth.jmir.org/2019/11/e12442
id doaj-31d210c2a66f4c2e9475b6524f8b2639
record_format Article
spelling doaj-31d210c2a66f4c2e9475b6524f8b26392021-05-02T19:28:31ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222019-11-01711e1244210.2196/12442Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot EvaluationRudolf, IsaPieper, KatharinaNolte, HelgaJunge, SibylleDopfer, ChristianSauer-Heilborn, AnnetteRingshausen, Felix CTümmler, Burkhardvon Jan, UteAlbrecht, Urs-VitoFuge, JanHansen, GesineDittrich, Anna-Maria BackgroundCystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to morbidity and mortality. Adherence is challenging in CF due to the high treatment burden and the lack of immediate health consequences in case of nonadherence. Lung function decline is particularly pronounced in the transition phase between 12 and 24 years of age. The improvement of self-management and self-responsibility and independence from parents and desire for normalcy are conflicting aspects for many adolescents with CF, which influence adherence to the time-consuming pulmonary therapy. Mobile health (mHealth) care apps could help to support self-management and independence and thereby reconcile seemingly conflicting goals to improve adherence, quality of life, and ultimately CF life expectancy. ObjectiveThis study aimed to (1) assess user behavior and satisfaction among adolescents and young adults with CF over an observation period of three months using an mHealth app; (2) identify areas of improvement for this mHealth app; and (3) compare overall and disease-specific satisfaction, lung function, and anthropometry before and after using the mHealth app. MethodsA total of 27 adolescents and young adults with CF (age range 12-24 years, mean age 16 years, SD 3 years; 14 females, 11 males) used a free mHealth app for three months of whom 25 provided questionnaire data for analysis at the end of the study. Data collection was carried out using questionnaires on usage characteristics and life satisfaction, and standardized assessment of lung function and anthropometry. ResultsThe use of the reminder function for medication declined from 70% (15/21) of the participants at week 4 to 65% (13/20) at week 8 of the observation period. At the end of the study, only 17% (4/23) of the participants wanted to continue using the app. Nevertheless, 56% (14/25) of participants saw the mobile app as a support for everyday life. Potential improvements targeting hedonistic qualities were identified to improve mHealth app adherence. Comparisons of satisfaction with different life aspects hinted at improvements or stabilization for the subitem respiration and the subitem lack of handicap by CF, suggesting that app use might stabilize certain CF-specific aspects of the weighted satisfaction with life. Lung function and anthropometry were not affected consistently. ConclusionsMost of the patients did not want to continue using the app after the study period. Only a few CF-specific aspects of weighted life satisfaction were possibly stabilized by the mHealth app; clinical parameters were not affected. Adaptation of the functions to adolescent-specific needs could improve the long-term use and thus positively affect the disease course.https://mhealth.jmir.org/2019/11/e12442
collection DOAJ
language English
format Article
sources DOAJ
author Rudolf, Isa
Pieper, Katharina
Nolte, Helga
Junge, Sibylle
Dopfer, Christian
Sauer-Heilborn, Annette
Ringshausen, Felix C
Tümmler, Burkhard
von Jan, Ute
Albrecht, Urs-Vito
Fuge, Jan
Hansen, Gesine
Dittrich, Anna-Maria
spellingShingle Rudolf, Isa
Pieper, Katharina
Nolte, Helga
Junge, Sibylle
Dopfer, Christian
Sauer-Heilborn, Annette
Ringshausen, Felix C
Tümmler, Burkhard
von Jan, Ute
Albrecht, Urs-Vito
Fuge, Jan
Hansen, Gesine
Dittrich, Anna-Maria
Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
JMIR mHealth and uHealth
author_facet Rudolf, Isa
Pieper, Katharina
Nolte, Helga
Junge, Sibylle
Dopfer, Christian
Sauer-Heilborn, Annette
Ringshausen, Felix C
Tümmler, Burkhard
von Jan, Ute
Albrecht, Urs-Vito
Fuge, Jan
Hansen, Gesine
Dittrich, Anna-Maria
author_sort Rudolf, Isa
title Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
title_short Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
title_full Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
title_fullStr Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
title_full_unstemmed Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
title_sort assessment of a mobile app by adolescents and young adults with cystic fibrosis: pilot evaluation
publisher JMIR Publications
series JMIR mHealth and uHealth
issn 2291-5222
publishDate 2019-11-01
description BackgroundCystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to morbidity and mortality. Adherence is challenging in CF due to the high treatment burden and the lack of immediate health consequences in case of nonadherence. Lung function decline is particularly pronounced in the transition phase between 12 and 24 years of age. The improvement of self-management and self-responsibility and independence from parents and desire for normalcy are conflicting aspects for many adolescents with CF, which influence adherence to the time-consuming pulmonary therapy. Mobile health (mHealth) care apps could help to support self-management and independence and thereby reconcile seemingly conflicting goals to improve adherence, quality of life, and ultimately CF life expectancy. ObjectiveThis study aimed to (1) assess user behavior and satisfaction among adolescents and young adults with CF over an observation period of three months using an mHealth app; (2) identify areas of improvement for this mHealth app; and (3) compare overall and disease-specific satisfaction, lung function, and anthropometry before and after using the mHealth app. MethodsA total of 27 adolescents and young adults with CF (age range 12-24 years, mean age 16 years, SD 3 years; 14 females, 11 males) used a free mHealth app for three months of whom 25 provided questionnaire data for analysis at the end of the study. Data collection was carried out using questionnaires on usage characteristics and life satisfaction, and standardized assessment of lung function and anthropometry. ResultsThe use of the reminder function for medication declined from 70% (15/21) of the participants at week 4 to 65% (13/20) at week 8 of the observation period. At the end of the study, only 17% (4/23) of the participants wanted to continue using the app. Nevertheless, 56% (14/25) of participants saw the mobile app as a support for everyday life. Potential improvements targeting hedonistic qualities were identified to improve mHealth app adherence. Comparisons of satisfaction with different life aspects hinted at improvements or stabilization for the subitem respiration and the subitem lack of handicap by CF, suggesting that app use might stabilize certain CF-specific aspects of the weighted satisfaction with life. Lung function and anthropometry were not affected consistently. ConclusionsMost of the patients did not want to continue using the app after the study period. Only a few CF-specific aspects of weighted life satisfaction were possibly stabilized by the mHealth app; clinical parameters were not affected. Adaptation of the functions to adolescent-specific needs could improve the long-term use and thus positively affect the disease course.
url https://mhealth.jmir.org/2019/11/e12442
work_keys_str_mv AT rudolfisa assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT pieperkatharina assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT noltehelga assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT jungesibylle assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT dopferchristian assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT sauerheilbornannette assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT ringshausenfelixc assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT tummlerburkhard assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT vonjanute assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT albrechtursvito assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT fugejan assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT hansengesine assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
AT dittrichannamaria assessmentofamobileappbyadolescentsandyoungadultswithcysticfibrosispilotevaluation
_version_ 1721488180876673024